Large Molecule Drug Bioanalysis Service
Creative Biolabs offers a cutting-edge large-molecule drug bioanalysis service that caters to the analytical needs of a wide array of biological products. Our expertise in pharmacokinetics, pharmacodynamics, immunogenicity, toxicokinetics, and biomarkers ensures high-quality services to meet the diverse needs of our customers in the development of therapeutic biological products. From discovery through preclinical to clinical development phases, our bioanalytical experts leverage state-of-the-art analytical platforms to deliver high-quality data in line with various regulatory standards.
The Importance of Large-Molecule Drug Bioanalysis
The realm of large-molecule drug bioanalysis is critical in modern drug development, where the focus has shifted towards biologics such as proteins, antibodies, ADCs, and more. Understanding the intricate pharmacokinetics, pharmacodynamics, and immunogenicity of these large molecules is paramount in ensuring their safety and efficacy. At Creative Biolabs, we offer a wide range of bioanalytical services tailored to meet the diverse needs of our clients throughout the drug development lifecycle.
To explore collaborative solutions - Schedule a formal consultation.
What We Can Offer
Creative Biolabs leverages state-of-the-art analytical platforms to deliver precise and reliable bioanalytical services for large-molecule drug analysis. Our instrumentation platforms include LC-MS/MS, ELISA Assay (Colorimetric, Fluorescence, Chemiluminescence), MSD, PCR, qPCR, Flow Cytometry, ELLA, and ELISpot. These cutting-edge technologies enable us to conduct esoteric and complex assay development, labile compound analysis, tissue sample analysis, antibody-drug conjugate (ADC) projects, and the determination of drug/antibody ratios for ADC projects.
| Discovery Bioanalysis of Large Molecules | Preclinical Bioanalysis of Large Molecules | Clinical Bioanalysis of Large Molecules |
|---|---|---|
|
Development of novel assays using analytical technologies like HPLC, LC/MS, LBA, and PCR platforms. Assay development for the analysis of ADA, NAb, and biomarkers of interest. |
Conducting GLP-compliant studies including PK, immunogenicity, and biomarker analysis. Assay optimization for therapeutic biologics in the preclinical development phase. |
Standardized global bioanalytical technology platforms for LBA, Serological, and Cell-based assays. Assay development and optimization for various bioanalytical needs in clinical studies. |
How Creative Biolabs' service Can Assist Your Projects
Highlights
Decades of Expertise
Creative Biolabs offers over 20 years of specialized experience in the biotechnology field, providing deep scientific knowledge to navigate the most complex bioanalytical research challenges.
State-of-the-Art Instrumentation
We utilize the industry's most advanced platforms to deliver superior data quality and high-throughput capabilities for every project we undertake.
Ultra-High Sensitivity
Our optimized workflows achieve detection limits down to pg/mL levels, ensuring the accurate quantification of low-abundance analytes in even the most challenging biological matrices.
Proactive Problem Solving
By applying a "quality by design" approach, we preemptively identify and mitigate potential matrix interference issues, guaranteeing robust and reproducible results for our clients.
Request a proposal for bespoke bioanalytical requirements.
Customer Reviews
-
Superior ADC Characterization
Creative Biolabs' hybrid LC-MS approach allowed us to differentiate between total and conjugated antibodies in complex tissue matrices. This facilitated a much clearer understanding of our linker stability compared to traditional methods. – M**s. S. -
Seamless Method Transfer
The team at Creative Biolabs facilitated the transfer of our early-stage research assay into a high-throughput format with impressive speed. Their troubleshooting of matrix interference was a decisive factor in our project's success. – S**h. K.
FAQs
How do you handle matrix interference in complex research samples?
We apply strategic minimum required dilution (MRD) and utilize proprietary blocking buffers. For highly complex samples, we implement immunoaffinity enrichment to isolate the analyte, ensuring maximum specificity and significantly reducing background noise levels.
Can you support both LBA and LC-MS platforms?
Yes, we offer both. While LBA provides high-throughput quantification, our Hybrid LC-MS/MS workflows offer absolute specificity for complex modalities like ADCs, allowing for the precise differentiation between conjugated and total antibody species.
Related Services
Immunogenic Host Cell Protein Analysis
We utilize advanced LC-MS and ELISA platforms to quantify residual host cell impurities, ensuring high-purity protein production and minimizing biochemical interference in research candidates.
Learn More →Biomarker Development Service
We provide end-to-end support for biomarker identification and validation using advanced multi-omics platforms, helping researchers correlate molecular concentration with specific biochemical responses and drug mechanisms.
Learn More →How to Contact Us
Creative Biolabs stands as a reliable partner for large-molecule drug bioanalysis services, offering expertise, cutting-edge technologies, and a commitment to regulatory compliance to support the development of innovative biologics in the pharmaceutical industry. If you would like to know more about our services, please feel free to contact us.
Download our brochure